<DOC>
	<DOC>NCT01092546</DOC>
	<brief_summary>To determine the level of association between the quantitative estimates of brain uptake of [18F]flutemetamol and the quantitative immunohistochemical and histochemistry estimates of amyloid levels in frontal lobe biopsy samples obtained from subjects during shunt placement for NPH.</brief_summary>
	<brief_title>Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus</brief_title>
	<detailed_description />
	<mesh_term>Hydrocephalus</mesh_term>
	<mesh_term>Hydrocephalus, Normal Pressure</mesh_term>
	<criteria>The subject is at least 50 years of age. The subjects' general health is adequate to comply with study procedures. The subject has been scheduled for a shunt placement procedure for the treatment of NPH. The subject has a contraindication for MRI or PET. The subject is pregnant or lactating. The subject has a known or suspected hypersensitivity/allergy to [18F]flutemetamol or to any of the excipients. The subject has participated in any clinical study using an investigational agent within 30 days of dosing.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Amyloid</keyword>
	<keyword>Normal pressure hydrocephalus (NPH)</keyword>
	<keyword>Positron Emission Tomography (PET)</keyword>
	<keyword>Standard uptake value ratios (SUVR)</keyword>
</DOC>